{"id":"https://openalex.org/W3106577029","doi":"https://doi.org/10.1136/gutjnl-2020-iddf.140","title":"IDDF2020-ABS-0057 Risk of incident hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) virus-infected patients treated with tenofovir disoproxil fumarate (TDF) versus entecavir (ETV): a US administrative claims analysis","display_name":"IDDF2020-ABS-0057 Risk of incident hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) virus-infected patients treated with tenofovir disoproxil fumarate (TDF) versus entecavir (ETV): a US administrative claims analysis","publication_year":2020,"publication_date":"2020-11-01","ids":{"openalex":"https://openalex.org/W3106577029","doi":"https://doi.org/10.1136/gutjnl-2020-iddf.140","mag":"3106577029"},"language":"en","primary_location":{"id":"doi:10.1136/gutjnl-2020-iddf.140","doi":"https://doi.org/10.1136/gutjnl-2020-iddf.140","is_oa":true,"landing_page_url":"https://doi.org/10.1136/gutjnl-2020-iddf.140","pdf_url":"https://gut.bmj.com/content/gutjnl/69/Suppl_2/A73.2.full.pdf","source":{"id":"https://openalex.org/S3251770","display_name":"Gut","issn_l":"0017-5749","issn":["0017-5749","1468-3288"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://gut.bmj.com/content/gutjnl/69/Suppl_2/A73.2.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100386557","display_name":"W. Ray Kim","orcid":"https://orcid.org/0000-0002-3030-860X","observed_orcids":["https://orcid.org/0000-0002-3030-860X"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ray Kim","raw_affiliation_strings":["Stanford University, Palo Alto, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University, Palo Alto, CA, USA","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085882972","display_name":"Laura E. Telep","orcid":"https://orcid.org/0000-0002-5692-7943","observed_orcids":["https://orcid.org/0000-0002-5692-7943"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Telep","raw_affiliation_strings":["Gilead Sciences, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091841617","display_name":"Mei L\u00fc","orcid":"https://orcid.org/0000-0002-3313-6428","observed_orcids":["https://orcid.org/0000-0002-3313-6428"]},"institutions":[{"id":"https://openalex.org/I154057602","display_name":"Henry Ford Health","ror":"https://ror.org/02kwnkm68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I154057602"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mei Lu","raw_affiliation_strings":["Henry Ford Health System, Detroit, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry Ford Health System, Detroit, USA","institution_ids":["https://openalex.org/I154057602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065063010","display_name":"Heribert Ramroth","orcid":"https://orcid.org/0000-0002-5925-414X","observed_orcids":["https://orcid.org/0000-0002-5925-414X"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heribert Ramroth","raw_affiliation_strings":["Gilead Sciences, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050079986","display_name":"John F. Flaherty","orcid":"https://orcid.org/0000-0001-7308-4880","observed_orcids":["https://orcid.org/0000-0001-7308-4880","https://orcid.org/0000-0002-4050-8234"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Flaherty","raw_affiliation_strings":["Gilead Sciences, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014107752","display_name":"Anuj Gaggar","orcid":"https://orcid.org/0000-0001-7865-001X","observed_orcids":["https://orcid.org/0000-0001-7865-001X"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anuj Gaggar","raw_affiliation_strings":["Gilead Sciences, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030408366","display_name":"Anand P. Chokkalingam","orcid":"https://orcid.org/0000-0001-5200-3033","observed_orcids":["https://orcid.org/0000-0001-5200-3033"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anand Chokkalingam","raw_affiliation_strings":["Gilead Sciences, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012619112","display_name":"Carol Yee Kwan Chan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carol Yee Kwan Chan","raw_affiliation_strings":["Gilead Sciences, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046835105","display_name":"Stuart C. Gordon","orcid":"https://orcid.org/0000-0001-8666-3849","observed_orcids":["https://orcid.org/0000-0001-8666-3849"]},"institutions":[{"id":"https://openalex.org/I154057602","display_name":"Henry Ford Health","ror":"https://ror.org/02kwnkm68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I154057602"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stuart Gordon","raw_affiliation_strings":["Henry Ford Health System, Detroit, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry Ford Health System, Detroit, USA","institution_ids":["https://openalex.org/I154057602"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A73.2","last_page":"A73"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.949999988079071},{"id":"https://openalex.org/keywords/chronic-hepatitis-b","display_name":"chronic hepatitis B","score":0.9950000047683716},{"id":"https://openalex.org/keywords/tenofovir-disoproxil-fumarate","display_name":"tenofovir disoproxil fumarate","score":0.9980000257492065},{"id":"https://openalex.org/keywords/entecavir","display_name":"entecavir","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antiviral-therapy","display_name":"antiviral therapy","score":0.8519999980926514},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.7799999713897705},{"id":"https://openalex.org/keywords/hepatocarcinogenesis","display_name":"hepatocarcinogenesis","score":0.6290000081062317},{"id":"https://openalex.org/keywords/long-term-cancer-risk","display_name":"long-term cancer risk","score":0.5669999718666077},{"id":"https://openalex.org/keywords/propensity-score-weighting","display_name":"propensity score weighting","score":0.6430000066757202},{"id":"https://openalex.org/keywords/commercially-insured-patients","display_name":"commercially insured patients","score":0.6840000152587891},{"id":"https://openalex.org/keywords/nucleos-t-ide-analogues","display_name":"nucleos(t)ide analogues","score":0.6840000152587891},{"id":"https://openalex.org/keywords/interferon-free-therapy","display_name":"interferon-free therapy","score":0.5659999847412109},{"id":"https://openalex.org/keywords/united-states","display_name":"United States","score":0.3109999895095825},{"id":"https://openalex.org/keywords/korea","display_name":"Korea","score":0.5680000185966492}],"concepts":[{"id":"https://openalex.org/C2776175608","wikidata":"https://www.wikidata.org/wiki/Q418586","display_name":"Entecavir","level":5,"score":0.8785667419433594},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.838373601436615},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7338979244232178},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.7100661396980286},{"id":"https://openalex.org/C2779344132","wikidata":"https://www.wikidata.org/wiki/Q155954","display_name":"Tenofovir","level":3,"score":0.6330536603927612},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5677514672279358},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5381079912185669},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5225728750228882},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.44651567935943604},{"id":"https://openalex.org/C2777813720","wikidata":"https://www.wikidata.org/wiki/Q1243018","display_name":"Coinfection","level":3,"score":0.43943771719932556},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.4304875135421753},{"id":"https://openalex.org/C2777382497","wikidata":"https://www.wikidata.org/wiki/Q6853","display_name":"Hepatitis B","level":2,"score":0.42029425501823425},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.3021298050880432},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.2044183611869812},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.20097005367279053},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.1694033443927765},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.1633111834526062}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/gutjnl-2020-iddf.140","doi":"https://doi.org/10.1136/gutjnl-2020-iddf.140","is_oa":true,"landing_page_url":"https://doi.org/10.1136/gutjnl-2020-iddf.140","pdf_url":"https://gut.bmj.com/content/gutjnl/69/Suppl_2/A73.2.full.pdf","source":{"id":"https://openalex.org/S3251770","display_name":"Gut","issn_l":"0017-5749","issn":["0017-5749","1468-3288"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/gutjnl-2020-iddf.140","doi":"https://doi.org/10.1136/gutjnl-2020-iddf.140","is_oa":true,"landing_page_url":"https://doi.org/10.1136/gutjnl-2020-iddf.140","pdf_url":"https://gut.bmj.com/content/gutjnl/69/Suppl_2/A73.2.full.pdf","source":{"id":"https://openalex.org/S3251770","display_name":"Gut","issn_l":"0017-5749","issn":["0017-5749","1468-3288"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3106577029.pdf","grobid_xml":"https://content.openalex.org/works/W3106577029.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4210920527","https://openalex.org/W4210499650","https://openalex.org/W3122956102","https://openalex.org/W4312157397","https://openalex.org/W3134000221","https://openalex.org/W3036100757","https://openalex.org/W3095855492","https://openalex.org/W4221100126","https://openalex.org/W3014008321","https://openalex.org/W3012427867"],"abstract_inverted_index":{"Background":[0],"TDF":[1,44,75,114,187,274,319,327],"and":[2,50,98,105,162,200,208,270],"ETV":[3,77,117,243,288],"are":[4],"first-line":[5],"treatments":[6],"for":[7,168,192,263],"CHB":[8,31,82,97,228,303],"virus":[9],"infection.":[10],"A":[11],"recent":[12,341],"analysis":[13,65,298],"of":[14,24,30,59,63,72,96,124,182,195,233,239,282,299,311,337],"nationwide":[15],"insurance":[16],"data":[17],"from":[18,343],"Korea":[19,47],"suggested":[20],"that":[21,238],"the":[22,69,180,193,230,306,308],"risk":[23,71,181,281,336],"HCC":[25,73,147,184,234,283,312],"may":[26],"vary":[27],"by":[28],"type":[29],"treatment;":[32],"however,":[33],"this":[34,64,297],"finding":[35],"was":[36,66,219,235,313],"based":[37,210],"on":[38,211],"a":[39,85,278,331],"limited":[40],"follow-up":[41,217],"period":[42],"following":[43],"approval":[45],"in":[46,48,55,78,84,198,221,305,315],"2012":[49],"has":[51],"not":[52],"been":[53],"replicated":[54],"large":[56],"datasets":[57],"outside":[58],"Asia.":[60,344],"The":[61],"objective":[62],"to":[67,113,128,142,154,178,285],"explore":[68],"long-term":[70],"with":[74,94,119,135,186,242,277,287,318,321,326,330,340],"vs.":[76],"treatment":[79,170,212,286,325],"na\u00efve":[80],"(TN)":[81],"patients":[83,93,111,225,240,304],"US":[86],"administrative":[87,99],"claims":[88,101],"dataset.":[89],"Methods":[90],"Among":[91],"158,272":[92],"evidence":[95],"medical":[100],"between":[102],"January":[103],"2006":[104],"September":[106],"2018,":[107],"we":[108,204],"identified":[109],"TN":[110,302],"exposed":[112],"(N=6,145)":[115],"or":[116,138,144,148,152],"(N=4,046)":[118],"at":[120],"least":[121],"1":[122],"year":[123],"continuous":[125],"enrollment":[126],"prior":[127,140,151],"cohort":[129],"entry.":[130],"Exclusion":[131],"criteria":[132],"included":[133],"coinfection":[134],"HCV,":[136],"HDV,":[137],"HIV;":[139],"exposure":[141],"peginterferon":[143],"nucleos(t)ide":[145],"analogues;":[146],"liver":[149],"transplant":[150],"up":[153],"6":[155],"months":[156],"after":[157],"initiating":[158],"treatment.":[159],"Absolute":[160],"rates":[161],"corresponding":[163],"95%":[164],"CIs":[165],"were":[166,176],"determined":[167],"each":[169],"group,":[171,265],"Cox":[172],"proportional":[173],"hazards":[174],"methods":[175],"used":[177],"estimate":[179],"incident":[183],"associated":[185,276,329],"vs":[188,223,252],"ETV.":[189,322],"To":[190],"account":[191],"effects":[194],"potential":[196],"differences":[197],"demographics":[199],"baseline":[201,267],"health":[202,268],"status,":[203],"incorporated":[205],"multivariable":[206],"adjustment":[207,262],"weighting":[209],"propensity":[213,271],"scores.":[214],"Results":[215],"Median":[216],"duration":[218],"comparable":[220],"TDF-":[222],"ETV-treated":[224],"among":[226],"TDF-treated":[227],"patients,":[229],"absolute":[231,309],"rate":[232,310],"approximately":[236],"half":[237],"treated":[241,317],"(0.32":[244],"per":[245,254],"100":[246,255],"PY":[247,256],"(CI:":[248,257],"0.23":[249],"\u2013":[250,259,293],"0.43)":[251],"0.61":[253],"0.45":[258],"0.80)).":[260],"After":[261,323],"age":[264],"sex,":[266],"conditions":[269],"score":[272],"weighting,":[273],"remained":[275,328],"significantly":[279,332],"decreased":[280,333],"compared":[284],"(HR:":[289],"0.56,":[290],"CI:":[291],"0.37":[292],"0.86).":[294],"Conclusions":[295],"In":[296],"commercially":[300],"insured,":[301],"US,":[307],"lower":[314],"those":[316],"than":[320],"adjustment,":[324],"long":[334],"term":[335],"HCC,":[338],"consistent":[339],"findings":[342]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2020-12-07T00:00:00"}